Catalyst Wire Dossier Catalyst Wire Dossier

ASP1585

ASP1585 · Astellas Pharma Inc.
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for ASP1585, covering 2010-05-27 to 2016-06-21. Get the full timeline:

Most recent: Clinical Trial Update: Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia [Phase 2]

See pricing